Barr Seasonale Clears FDA: Labeling Includes Breakthrough Bleeding Warning

Labeling for Barr's oral contraceptive Seasonale advises prescribers to weigh the convenience of fewer planned menses against the inconvenience of increased breakthrough bleeding associated with the drug